Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Anyone know why trading of DNA is halted?
Print the post Back To Top
No. of Recommendations: 0
They reported earnings.

$0.35 vs. estimate of $0.30.

Big upside for Herceptin and Avastin vs. estimates

Downside for Rituxan and Tarceva vs. estimates.


-chris

Print the post Back To Top
No. of Recommendations: 0
back in ah

good luck

tr
Print the post Back To Top
No. of Recommendations: 0
+4 AH but expect some volatility during the conference call which you can listen to right now at this link if you want to:

http://biz.yahoo.com/cc/3/60483.html
Print the post Back To Top
No. of Recommendations: 0
In the CC, they discuss the Cabilly patent issue. Revenues from the patent accounted for one cent per share of earnings in Q3 and would be approx. 4 cents per share in quarter. This represents the potential loss to DNA should the patent ruling eventually go against them.

-chris
Print the post Back To Top
Advertisement